Concepedia

Mark Sherman

MS

Statistics

Publications

6

Citations

3.6K

H-Index

6

Active since

2011

Affiliations

University of Louisville(Current)

University Hospital in Motol

University of Washington

Iuliu Hațieganu University of Medicine and Pharmacy

Mossakowski Medical Research Institute, Polish Academy of Sciences

Mark Sherman is an author at University of Louisville specializing in metabolic syndrome, diabetes, and medicine.

Top concepts

Publications per year

2011–2019

6

Publications

6

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

PRIMARY RETINAL DETACHMENT REPAIR

Shlomit Schaal, Mark Sherman, Charles C. Barr et al. · Retina · 2011 · 119 citations

UNTREATED OBSTRUCTIVE SLEEP APNEA HINDERS RESPONSE TO BEVACIZUMAB IN AGE-RELATED MACULAR DEGENERATION

Shlomit Schaal, Mark Sherman, Brooke Nesmith et al. · Retina · 2016 · 34 citations

TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION

Janelle M. Fassbender, Mark Sherman, Charles C. Barr et al. · Retina · 2016 · 32 citations

1–5 of 6